BeStock  

United Therapeutics UTHR

US equityMarket cap rank #819Drug Manufacturers - Specialty & Generic
$554.73 −$4.37 (-0.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $550.23 -0.81%
Open$561.20
Prev close$559.10
Day range$551.77 – $563.12
Volume531.8K
Market cap$23.63B
P/E (TTM)20.9
Dividend yield–

UTHR Stock News

Headlines matching United Therapeutics or the UTHR ticker, most recent first.

  • Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $704 NegativeMarket news · 9 Sep 2026 · Direct mention
  • United Therapeutics(UTHR.US) Officer Sells US$4.57 Million in Common StockMarket news · 30 Sep 2026 · Direct mention
  • United Therapeutics(UTHR.US) Officer Sells US$4.52 Million in Common StockMarket news · 29 Sep 2026 · Direct mention
  • United Therapeutics(UTHR.US) Officer Sells US$4.5 Million in Common StockMarket news · 26 Sep 2026 · Direct mention
  • Goldman Sachs Initiates United Therapeutics(UTHR.US) With Sell Rating, Announces Target Price $321Market news · 25 Sep 2026 · Direct mention
  • Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $700Market news · 2 Sep 2026 · Direct mention
  • TD Cowen Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $675Market news · 2 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $660Market news · 7 Aug 2026 · Direct mention
  • RBC Capital Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $677 NegativeMarket news · 6 Aug 2026 · Direct mention
  • Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $700 NegativeMarket news · 6 Aug 2026 · Direct mention
  • RBC Capital Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $704 PositiveMarket news · 9 Jul 2026 · Direct mention
  • Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $738Market news · 31 Jul 2026 · Direct mention
  • J.P. Morgan Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $687 PositiveMarket news · 23 Jul 2026 · Direct mention
  • Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $714 NegativeMarket news · 10 Jul 2026 · Direct mention
  • BofA Securities Maintains United Therapeutics(UTHR.US) With Hold Rating, Cuts Target Price to $613 NegativeMarket news · 10 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on UTHR.

Sign in to join the discussion.

Scroll to Top